- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
By Johnny Green for Weed News
Americans for Safe Access (ASA) has released its 2019 report card titled, “2019 State of the States Report: An Analysis of Medical Cannabis Access in the United States” in conjunction with the start of the National Conference of State Legislatures (NCSL) Legislative Summit in Nashville, Tennessee.
The nearly 200-page report provides a detailed analysis of the state of medical cannabis programs in 47 states, the District of Columbia, and four territories on a ‘A’ to ‘F’ scale. States were assessed in six categories: 1) Patient rights and civil protections; 2) Access to medicine; 3) Ease of navigation; 4) Functionality; 5) Consumer safety and provider requirements; and 6) Medical cannabis as a tool in combating the opioid epidemic.
“Thousands of lawmakers come to NCSL looking for policy ideas to bring back to their home state. By releasing our State of the States Report at the Legislative Summit, we are providing legislatures clear ways to improve access to medical cannabis in their state” said David Mangone, Director of Government Affairs for Americans for Safe Access. “Our report includes specific improvements for individual state medical cannabis programs like adopting product safety provisions as well as model legislation that suggests universal improvements for medical cannabis programs across the country. This report is a fantastic tool for lawmakers to serve medical cannabis patients in their jurisdictions.”
Illinois and Oregon received top marks for their medical cannabis programs, both receiving an A-. Meanwhile, every state that limits access to low-THC products or cannabidiol-only received a failing grade. Additionally, despite passing legislation for a comprehensive medical cannabis program, West Virginia also received a failing grade due to delays in implementation.
Findings of the report also show that medical cannabis access has improved significantly nationwide since California first passed Proposition 215 in 1996. Between the 2018 and 2019 state legislative sessions there were over 2,000 bills introduced across the country that dealt with creating or amending existing cannabis programs. While this flood of legislation is welcome progress, not all bills are created equal.
The State of the States Report also includes responses from a patient feedback survey of over 500 individuals. This survey revealed that even in states with adequate medical cannabis programs, affordability has been one of the most consistent critiques of patients and remains the single greatest challenge that patients face. While some states have worked to clarify the role of insurance and insurance companies when it comes to medical cannabis, no state has yet adopted a law that permits or requires insurance companies to cover the costs.
During the Legislative Summit, in which thousands of legislators are expected to attend, ASA will be handing out printed versions of the report to legislators as well as co-hosting two events in Nashville, TN to discuss the report. In addition, ASA will be exhibiting at the NCSL summit. ASA’s booth number is 1216.